SCHEMBL4034809

SCHEMBL4034809

O=C(NC1CCCCC1)C(C1CCCCC1)C1(c2ccccn2)Nc2ccc(F)cc2N1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.42
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
MET P08581 1/20 0.39
KDR P35968 1/20 0.39
MERTK Q12866 1/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 3/20 0.39
GAA P10253 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTR2B P41595 1/20 0.37
C3AR1 Q16581 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4040310 0.91 EGFR (0.41) IDO1EGFRERBB2METKDR
SCHEMBL4035291 0.91 EGFR (0.42) EGFRERBB2METKDRMERTK
SCHEMBL4041039 0.87 CYP3A4 (0.41) IDO1EGFRERBB2METKDR
SCHEMBL3651405 0.83 IDO1 (0.39) IDO1EGFRERBB2METKDR
SCHEMBL4040710 0.79 NPC1 (0.42) IDO1NPC1RAB9APOLBALDH1A1
SCHEMBL4041164 0.79 NPC1 (0.42) IDO1NPC1RAB9APOLBALDH1A1
SCHEMBL4036972 0.79 NPC1 (0.41) IDO1NPC1RAB9APOLBALDH1A1
SCHEMBL4036796 0.79 NPC1 (0.41) IDO1NPC1RAB9APOLBALDH1A1
SCHEMBL4041108 0.79 NPC1 (0.46) IDO1NPC1RAB9APOLBGAA
SCHEMBL4038973 0.77 NPC1 (0.46) NPC1RAB9APOLBALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed